Australian biotechnology company Marinova Pty Ltd has been named Health & Wellness Ingredient Innovator of the Year in the GH&P International Life Sciences Awards 2023.
Marinova is dedicated to the development and production of high purity seaweed extracts for the betterment of human health. The company specialises in the research, development and manufacture of fucoidan compounds – highly bioactive polysaccharides derived from select species of brown seaweed.
The company’s unique portfolio of Maritech® fucoidan extracts are the world’s only high purity, certified organic fucoidan ingredients with global regulatory acceptance.
Sustainably sourced and clinically validated, Maritech® organic fucoidans are high purity seaweed extracts sought after by some of the world’s most trusted healthcare brands. They are included as premium ingredients in market-leading nutritional supplements, functional foods and beverages, skincare formulations and animal health products.
Speaking of the award, company CEO Mr Paul Garrott said, “The unrivalled quality and efficacy of Maritech® organic fucoidans is based on two decades of rigorous scientific investigation and the development of an advanced proprietary extraction process. Maritech® organic fucoidans are ideal for product innovators seeking novel ingredients with a clear point of differentiation.”
Now in their eighth year, the International Life Sciences Awards are a merit-based program recognising excellence in the global life sciences industry. Nominations extend across the human, animal and plant life sectors, and awards celebrate worthy companies who have excelled in their fields.
The GH&P award supplement profiles the 2023 award winners.
